Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy

Summary

This study was to determine whether ranolazine was effective in the treatment of neuropathic pain in patients with coronary artery disease. Eligibility required neurological examination by the study doctor and assessment of the patient's pain. Eligible participants were randomized to receive blinded study medication for a total of 12 weeks.

Timeline

Start

2009-01

Primary completion

2009-06

Completion

2009-06

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of enrollment”

Drugs

Indications